Capital Research Global Investors »

Denali Therapeutics shares owned by Capital Research Global Investors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Capital Research Global Investors from 13F filings

Historical chart of Capital Research Global Investors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Capital Research Global Investors

Quarter filed Position value Share count Share price at filing
2023-09-30 $59M 2.9M 20.63
2023-06-30 $84M 2.8M 29.51
2023-03-31 $57M 2.5M 23.04
2022-12-31 $63M 2.3M 27.81